These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20624075)

  • 1. Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice.
    Sango K; Joseph A; Patel M; Osiecki K; Dutta M; Goldstein H
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):735-46. PubMed ID: 20624075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse.
    Choudhary SK; Archin NM; Cheema M; Dahl NP; Garcia JV; Margolis DM
    J Virol; 2012 Jan; 86(1):114-20. PubMed ID: 22013038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo.
    Zhang L; Jiang Q; Li G; Jeffrey J; Kovalev GI; Su L
    Blood; 2011 Jun; 117(23):6184-92. PubMed ID: 21505190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 infection and pathogenesis in a novel humanized mouse model.
    Zhang L; Kovalev GI; Su L
    Blood; 2007 Apr; 109(7):2978-81. PubMed ID: 17132723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo.
    Jiang Q; Zhang L; Wang R; Jeffrey J; Washburn ML; Brouwer D; Barbour S; Kovalev GI; Unutmaz D; Su L
    Blood; 2008 Oct; 112(7):2858-68. PubMed ID: 18544681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of HIV-1 infection in the humanized Rag2-/-γc-/- mouse model.
    Sanchez FM; Berges BK
    Methods Mol Biol; 2013; 1031():215-22. PubMed ID: 23824904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
    Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
    Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.
    Lavender KJ; Pang WW; Messer RJ; Duley AK; Race B; Phillips K; Scott D; Peterson KE; Chan CK; Dittmer U; Dudek T; Allen TM; Weissman IL; Hasenkrug KJ
    Blood; 2013 Dec; 122(25):4013-20. PubMed ID: 24021673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
    Amado RG; Jamieson BD; Cortado R; Cole SW; Zack JA
    J Virol; 1999 Aug; 73(8):6361-9. PubMed ID: 10400728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Active HIV-1 Infection in CD34
    Latinovic OS; Neal LM; Tagaya Y; Heredia A; Medina-Moreno S; Zapata JC; Reitz M; Bryant J; Redfield RR
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):718-728. PubMed ID: 31099257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea.
    López M; Benito JM; Lozano S; Barreiro P; Martínez P; González-Lahoz J; Soriano V
    AIDS; 2004 Jun; 18(9):1251-61. PubMed ID: 15362657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy.
    Cheng L; Ma J; Li G; Su L
    Front Immunol; 2018; 9():817. PubMed ID: 29725337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
    Gorantla S; Sneller H; Walters L; Sharp JG; Pirruccello SJ; West JT; Wood C; Dewhurst S; Gendelman HE; Poluektova L
    J Virol; 2007 Mar; 81(6):2700-12. PubMed ID: 17182671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.
    Ince WL; Zhang L; Jiang Q; Arrildt K; Su L; Swanstrom R
    J Virol; 2010 Mar; 84(6):2740-52. PubMed ID: 20042504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year.
    Berges BK; Akkina SR; Remling L; Akkina R
    Virology; 2010 Feb; 397(1):100-3. PubMed ID: 19922970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.